You're using an outdated browser. To get the most out of this website, as well as many others, please consider upgrading to a modern browser, such as Google Chrome, Mozilla Firefox, or Microsoft Edge.

Open menu


Conditional approval for Hansa’s kidney transplant drug

The EU Commission has granted conditional approval for use of Hansa Biopharma’s Idefirix (imlifidase) to desensitise kidney transplant patients with a highly sensitised immune system.